Our companies
A unique value chain for public health
With its companies, Institut Mérieux represents an industrial and scientific force committed across all fronts of public health.
Our Complementary Areas of Expertise
As majority shareholder of bioMérieux, Mérieux NutriSciences, Transgene and Mérieux Equity Partners, and strategic partner of Ceva and OXB, Institut Mérieux operates across the entire health value chain: prevention, diagnostics, nutrition, immunotherapy and biotechnology innovation.
This complementarity of activities enables a comprehensive and integrated approach to human and animal health challenges, consistent with a long-term vision. Institut Mérieux’s teams support each company while respecting their governance and independence, to address the challenges of today and tomorrow.
Our complementary areas of expertise
Filter by continent:
Number of employees by region
11,100
employees Europe – Middle East – Africa
11,200
employees Americas
3,600
employees Asia – Pacific
€4,9
billion in revenue
11%
of revenue reinvested in R&D
